866-997-4948(US-Canada Toll Free)

Cough, Cold, Flu and Allergy Remedies - US - April 2017

Published By :

Mintel

Published Date : Apr 2017

Category :

Pharmaceutical

No. of Pages : N/A

US sales of OTC cough, cold, flu, and allergy remedies have had healthy growth for the past few years, yet slowed from 2015-16. A mild cold/flu season, effective flu vaccines, and more moderate success in Rx-to-OTC switches is likely to have tempered market growth. Mintel expects growth to continue on a slow and steady pace as consumers continue to rely on OTC remedies to relieve the symptoms of colds, flu, or allergies. New product introductions, along with a harsh cold and flu season, will drive growth in the market. Family households represent the most significant demographic opportunity for brand marketers while the choice not to treat challenges growth.

Table of Content

OVERVIEW
What you need to know
Definition

EXECUTIVE SUMMARY
The issues
Overall OTC cough, cold, flu, and allergy market slows
Figure 1: Total US sales of cough, cold, flu, and allergy remedies, at current prices, 2011-16
Mainstream children’s medications decline, while natural grows
Figure 2: MULO sales of select children’s cold and sinus brands, rolling 52 weeks 2015 and 2016
Young adults, a key consumer, most willing to forgo OTC medication when sick
Figure 3: No need to treat barrier to OTC remedy use, by gender and age, January 2017
The opportunities
Help mom prepare for illnesses
Figure 4: Purchase medication to be prepared, by parental status, January 2017
Product claims are the key to choosing products
Figure 5: OTC selection factors, by rank, January 2017
Free-from claims give perception of natural without compromising potency
Figure 6: Take natural remedies in addition to conventional, January 2017
What it means

THE MARKET – WHAT YOU NEED TO KNOW
Cough, cold, flu, and allergy market experiences minor growth in 2016
People take measures to prevent illness
Alternative and nontreatment threaten OTC remedy use
People get sick, how many depends on severity of the cold and flu season
Families get sick the most; number of households with kids declining

MARKET SIZE AND FORECAST
Regularity of cough, cold, flu, and allergy ailments supports stable market growth
Figure 7: Total US sales and fan chart forecast of cough, cold, flu, and allergy remedies, at current prices, 2011-21
Figure 8: Total US sales and forecast of cough, cold, flu, and allergy remedies, at current prices, 2011-21

MARKET BREAKDOWN
Market segments post modest gains
Figure 9: Total US retail sales and forecast of cough, cold, flu, and allergy remedies, by segment, at current prices, 2011-21

MARKET PERSPECTIVE
Proactive measures are taken to prevent illness
Figure 10: Proactive health measures, January 2017
Figure 11: Use of vitamins or minerals and supplements in the past year, by ailment, January 2017
Flu vaccine protects against flu, reducing OTC remedy needs
Figure 12: Yearly flu shot and first time getting flu shot, January 2017
Figure 13: Vaccine effectiveness (VE) estimates for influenza seasons from 2005-16
Home remedies help some people cope with symptoms
Figure 14: Use of a home remedy in the past year, by ailment, January 2017
Some suffer through without intervention
Figure 15: Did nothing for ailment in the past year, by ailment, January 2017

MARKET FACTORS
People get sick and it can happen year-round
Figure 16: Ailments experienced seasonally in the past year, January 2017
Mild 2015-16 flu season
Figure 17: Seasonal flu severity, 2010-16
Households with children are declining
Figure 18: US households, by presence of related children, 2006-16

KEY PLAYERS – WHAT YOU NEED TO KNOW
Market leaders change places, competition intensifies
Nasal sprays, streamlined offerings, children’s external remedies thrive
Cough/throat stagnate, mainstream children’s remedies decline, allergy brands try sales tactic
Private label introductions and new allergy options will impact market
Children are the key for supplementary growth

COMPANY AND BRAND SALES OF COUGH, COLD, FLU, AND ALLERGY REMEDIES
Reckitt Benckiser and Bayer change places in the ranks
Figure 19: Sales of cough, cold, flu, and allergy remedies, by company, 2015 and 2016
Mucinex and Vicks lead sales of cold and sinus remedies
Bayer introduces line extensions, more natural formulas
J&J experiences solid gains
Figure 20: MULO sales of cold/sinus remedies, by leading companies and brands, rolling 52 weeks 2015 and 2016

WHAT’S WORKING?
Sales of nasal sprays continue to grow with new 2016 introductions
Figure 21: MULO sales of nasal sprays, by select brands, 2015 and 2016
Vicks streamlines its offerings; relaunches sinus brand
External therapies for children are thriving
Figure 22: MULO sales of chest rubs and nasal aspirators, 2011-16

WHAT’S STRUGGLING?
Overall sales of cough/throat remedies stagnate
Figure 23: MULO sales of cough/throat remedies, by leading companies and brands, rolling 52 weeks 2015 and 2016
Mainstream children’s medications take a hit
Figure 24: MULO sales of select children’s cold and sinus brands, rolling 52 weeks 2015 and 2016
Allergy tablet brands aim to improve value proposition

WHAT’S NEXT?
Private label sales will get a boost from new formulation introductions
Plateauing allergy sales could gain boost from children’s launches
Figure 25: MULO sales of Claritin and Zyrtec allergy remedies and children’s allergy remedies, rolling 52 weeks 2015 and 2016
New allergy relief introductions give consumers more options
Dye-free offers more natural approach without compromising potency
Essential oils offer alternative cold, cough, and sinus relief

THE CONSUMER – WHAT YOU NEED TO KNOW
Proactive measures are taken to prevent illnesses
Most everyone gets sick, and there’s somewhat of a seasonal pattern
OTC medications are the top remedy choice regardless of the ailment
Consumers focus on product claims
Some people are willing to suffer without treatment
Natural remedies have a place in the medicine cabinet

HEALTH ATTITUDES
People take proactive measures to keep illness at bay
Figure 26: Proactive health attitudes, January 2017
Women and older adults are more vigilant
Figure 27: Proactive health attitudes, by gender, generation, and parental status, January 2017
There is seasonality in the minds of most consumers
Figure 28: Seasonality of cold, cough, and flu season and purchase medication to be prepared, January 2017
Illness is less seasonal for older adults
Figure 29: Seasonality of cold, cough, and flu season, by age, January 2017
Moms prepare
Figure 30: Purchase medication to be prepared, by parental status, January 2017
Those making preparation purchases also taking other proactive measures
Figure 31: Purchase medication to be prepared, by proactive health attitudes, January 2017

AILMENTS EXPERIENCED
Illnesses are common
Figure 32: Ailments experienced in the past year (net), January 2017
Young adults are most susceptible to illness
Figure 33: Ailments experienced in the past year (net), by age, September 2016
Adults and kids share the germs
Figure 34: Ailments experienced in the past year (net), by parental status, January 2017
Employed adults need more sick days
Figure 35: Ailments experienced in the past year (net), by employment status, January 2017
Cold and cough occur in cold months; allergies spike in spring
Figure 36: Ailments experienced in the past year, by season, January 2017

AILMENT TREATMENT
OTC medications are turned to most often, no matter the ailment
Figure 37: Correspondence analysis – Cough, cold, flu and allergy remedies treatment, January 2017
Correspondence methodology
Figure 38: Treatment of ailment, by ailment, January 2017
Young men and Hispanics are least likely to treat with OTC medications
Figure 39: OTC medication used for treatment of ailment, by gender and age, and by Hispanic origin, January 2017
Parents, more so than nonparents, turn to homeopathic remedies
Figure 40: OTC homeopathic remedy used for treatment of ailment, by parental status, January 2017
Older women using an Rx for allergies, younger adults opt to do nothing
Figure 41: Used prescription or nothing for treatment of allergies, by age, and by gender and age, January 2017

OTC SELECTION FACTORS
Product claims are central to choice
Figure 42: OTC selection factors, by rank, January 2017
Women more drawn to certain claims, men to brand name
Figure 43: Specific symptom claim, nondrowsy formula, brand name impact on OTC medication choice, any rank (net), by gender, January 2017
Older adults are influenced by a professional recommendation
Figure 44: Recommendation impact on OTC medication choice, any rank (net), by age, January 2017
Parents factor in naturalness and on-the-go convenience
Figure 45: Natural ingredients and easy to take on-the-go impact on OTC medication choice, any rank (net), by parental status, and by parental status by gender, January 2017

BARRIERS TO OTC REMEDY USE
Willingness to suffer without is the main barrier to OTC remedy use
Figure 46: Barriers to OTC remedy use, January 2017
Young adults most willing to forgo OTC medication
Figure 47: No need to treat as barrier to OTC remedy use, by gender and age, January 2017
Lack of seasonality limits the need to treat
Figure 48: No illness season by no need to treat, January 2017

NATURAL REMEDY PERCEPTIONS
Natural remedies are prominent
Figure 49: Natural remedy use, January 2017
Figure 50: Don’t know which natural remedies treat symptom, by female by age, January 2017
Younger generations and parents seek natural options
Figure 51: Natural remedy use, by generation, and by parental status by gender, January 2017
Some adults don’t buy into natural
Figure 52: Natural remedy perceptions, January 2017
Opportunity to encourage stocking up on natural remedies
Figure 53: Purchase medication to be prepared, by natural remedy use, January 2017

APPENDIX – DATA SOURCES AND ABBREVIATIONS
Data sources
Sales data
Fan chart forecast
Consumer survey data
Abbreviations and terms
Abbreviations

APPENDIX – MARKET
Figure 54: Total US sales and forecast of cough, cold, flu, and allergy remedies, at inflation-adjusted prices, 2011-21
Figure 55: Total US retail sales and forecast of cold/sinus remedies, at current prices, 2011-21
Figure 56: Total US retail sales and forecast of cough/throat remedies, at current prices, 2011-21
Figure 57: Total US retail sales and forecast of allergy remedies, at current prices, 2011-21
Figure 58: Total US retail sales of cough, cold, flu, and allergy remedies, by segment, at current prices, 2014 and 2016
Figure 59: Total US retail sales of cough, cold, flu, and allergy remedies, by channel, at current prices, 2011-16

List of Table

NA

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *